(Q44437779)

3 December 2017

title

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial (English)

1 reference

3 December 2017

0 references

1 reference

1 reference

dilated cardiomyopathy

1 reference

9

1 reference

3 December 2017

Antonio Cittadini

6

0 references

author name string

Gennaro Cice

1

1 reference

3 December 2017

Luigi Ferrara

2

1 reference

3 December 2017

Antonello D'Andrea

3

1 reference

3 December 2017

Salvatore D'Isa

4

1 reference

3 December 2017

Attilio Di Benedetto

5

1 reference

3 December 2017

Pina Elvira Russo

7

1 reference

3 December 2017

Paolo Golino

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Journal of the American College of Cardiology

3 December 2017

published in

1 reference

3 December 2017

volume

41

1 reference

3 December 2017

issue

9

1 reference

3 December 2017

page(s)

1438-1444

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Chronic renal failure--a vasculopathic state

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Morbidity and mortality on maintenance haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Sympathetic overactivity in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Sympathetic Overactivity in Hypertensive Patients with Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Clinical relevance of cytokine production in hemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900241-9

7 January 2021

10.1016/S0735-1097(03)00241-9

Identifiers

DOI

1 reference

3 December 2017

1 reference